Increasing Prevalence Of Autoimmune Diseases Driving Market Growth Through Targeted Treatment Innovations: A Significant Driver Propelling The Leukapheresis Market In 2025

Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Is the Leukapheresis Market Size and Projected Growth Rate?
The market for leukapheresis has witnessed a robust expansion in the past few years. The market, which was valued at $66.80 billion in 2024, is predicted to swell to $72.23 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.1%. The surge during the historical duration has been driven by factors such as increased incidence of leukemia and autoimmune disorders, heightened necessity for tailor-made medicine, advancements in stem cell investigation, refinements in apheresis techniques, broader clinical trial engagements, and enhanced consciousness about the applications of immunotherapy.

In the next few years, the leukapheresis market size is forecasted to experience substantial growth, reaching a value of $97.83 billion in 2029 with a compound annual growth rate (CAGR) of 7.9%. Factors contributing to this growth in the forecast period include the increasing demand for individualized cell therapies, a rise in immuno-oncology clinical trials, broadening acceptance in regenerative medicine, expansion of biopharmaceutical manufacturing, enhanced reimbursement policies, and heightened awareness of cell-based treatments and research. Key trends in the forecast period consist of progress in cell separation technology, AI integration for procedure enhancement, creation of portable leukapheresis devices, advancements in cell and gene therapy, improved donor screening processes, and the use of cloud-based systems for data tracking.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/customise?id=24277&type=smp

What Are the Major Segments in the Leukapheresis Market?
The leukapheresis market covered in this report is segmented -

1) By Type: Granulocyte Apheresis, Lymphocyte Apheresis, Monocyte Apheresis
2) By Product: Leukapheresis Devices, Centrifugal Devices, Membrane Separators, Leukapheresis Disposables
3) By Application: Research Application, Cancer Research, Immunology Research, Therapeutics Application, Hematologic Disorders, Autoimmune Diseases, Other Applications
4) By End User: Blood Component Providers And Blood Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Transfusion Centers

Subsegments:
1) By Granulocyte Apheresis: Neutrophil Apheresis, Eosinophil Apheresis, Basophil Apheresis
2) By Lymphocyte Apheresis: T-Cell Apheresis, B-Cell Apheresis, Natural Killer (NK) Cell Apheresis
3) By Monocyte Apheresis: Classical Monocytes, Non-Classical Monocytes, Intermediate Monocytes

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24277&type=smp

What Are The Driving Leukapheresis Market Evolution?
Anticipated growth in the leukapheresis market is largely attributed to the increasing prevalence of autoimmune diseases. These diseases are characterized by the immune system's erroneous assault on the body's own healthy tissues. A disruption in the immune balance due to lack of microbial exposure in early life and contemporary environmental factors is leading to a rise in such disorders. Leukapheresis is employed to manage these diseases by the targeted removal of detrimental white blood cells, which are responsible for the immune system's self-destructive behavior. For instance, as cited by Versorgungsatlas.de, a German organization, out of 73,241,305 insured people in 2022, 6,304,340 were identified with a minimum of one autoimmune disease, taking the gross prevalence rate to 8.61% in November 2024. Hence, the accelerating rate of autoimmune diseases is fueling the expansion of the leukapheresis market.

Which Firms Dominate The Leukapheresis Market Segments?
Major companies operating in the leukapheresis market are Fresenius Kabi, Grifols S.A., Terumo BCT Inc., Nikkiso Co., STEMCELL Technologies Inc., Haemonetics Corporation, Macopharma, Discovery Life Sciences, BioIVT LLC, StemExpress LLC, MEDICA S.p.A, AllCells LLC, Caltag Medsystems Ltd., Miltenyi Biotec, Immune Therapy Holdings AB, Cellsep Laboratories, Accegen Biotec, Key Biologics LLC, HemaCare Corporation, Puriblood Medical, Cytopheron Technologies, Adacyte Therapeutics.

What Are the Major Trends Shaping the Leukapheresis Market?
The focus of leading enterprises in the leukapheresis industry has shifted towards innovations like crafting GMP-grade leukopaks in an effort to elevate the calibre and effectiveness of cell therapy production. GMP-grade leukopaks, derived from leukapheresis, are processed strictly under good manufacturing practice (GMP) regulations to secure high survival rate and functionality of the harvested cells for therapeutic uses. For example, Sanguine Biosciences, a biotech firm from the US, introduced LeukoCer, a GMP-grade leukopak, in November 2024, to expedite the procedures and hasten the development of cell therapy. LeukoCert, which is available in fresh whole or half packs, is manufactured following strict GMP criteria. This not only aids investigators in progressing their studies but also to assist them in rapidly introducing new cell therapies to the marketplace.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/leukapheresis-global-market-report

Which Is The Largest Region In The Leukapheresis Market?
North America was the largest region in the leukapheresis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leukapheresis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Leukapheresis Market?
2. What is the CAGR expected in the Leukapheresis Market?
3. What Are the Key Innovations Transforming the Leukapheresis Industry?
4. Which Region Is Leading the Leukapheresis Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.